Xinbang Pharmaceuticals financing and financing information shows that on December 24, 2021, financing net buying 6,578,700 yuan; financing balance of 277 million yuan, an increase of 2.44% over the previous day.
Financing, financing bought 34,114,600 yuan on the day, financing repayment of 27,535,900 yuan, financing net buy 657.87 million yuan. In terms of financing, financing sold 365,200 shares, financing repayment of 55,400 shares, financing balance of 2,111,100 shares, financing balance of 14,967,700 yuan. The total balance of financing and bond financing is 292 million dollars.
Expanded Information
Guizhou Xinbang Pharmaceutical Co., Ltd (abbreviation: Xinbang Pharmaceutical, stock code: 002390) was founded in January 1995, the registered office is located in Luodian County, Qiannan Miao Buyi Autonomous Prefecture, Guizhou Province, is a centralized medicinal herbs GAP planting, research and development of new medicines, drug production and sales as one of the high-tech pharmaceutical enterprises.2010 April 16, the company's stock was listed on the Shenzhen Stock Exchange. On April 16, 2010, the company's shares were listed and traded on the Shenzhen Stock Exchange.
In April 2019, the company released its 2018 annual report, in 2018 the company realized operating income of 6,580,278,900 yuan, and realized a net profit of -1,283,183,300 yuan.
Company products and services
Medical services segment:
The company owns a number of medical institutions, such as Guizhou Cancer Hospital, Baiyun Hospital of Guizhou Medical University, Wudang Hospital of Guizhou Medical University, Anshun Hospital of Guizhou Medical University, Renhuai New Sunrise Hospital, Liuzhi Boda Hospital, Liupanshui Anjiu Hospital and Daochen Hospital of Traditional Chinese Medicine, which are located in Guiyang, Zunyi, Anshun, Liupanshui and other places, with nearly 6,000 beds, and through the "Guimedian Cloud" "Zunmedian Cloud Hospital" Internet medical service platform, to realize the online and offline comprehensive medical layout.
Pharmaceutical distribution segment:
The company owns more than 20 distribution companies, such as Kekai Pharmaceuticals, Zhodai Pharmaceuticals, Xinbang Pharmaceuticals, Kekai Pharmacy, Xindali Biotech, Zhongkang Ze'ai Medical Devices, etc., which are mainly engaged in the sale of medicines and medical devices and distribution services, with tens of thousands of operating varieties, basically covering the purchasing needs of tertiary hospitals, and forming a distribution network centered on Guiyang, covering Qiannan, Zunyi, Bijie, Tongjie, and Tongjie. It has also formed a distribution network centered in Guiyang, covering key regions such as Qiannan, Zunyi, Bijie and Tongren, and radiating across the province. The retail network basically covers the company's hospitals and major cooperative hospitals, and will further increase the number of stores in Guiyang, Zunyi, etc. to create an influential chain brand.